C003P: Adalimumab Biosimilar, TNF alpha Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody adalimumab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by adalimumab.PA000658-PA1844: ADAM 17 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.
APIM050358: AN2728 (CRISABOROLE)
CAS No.: 906673-24-3.
Purity: >99.5% by HPLC.
QC: HPLC, 1HNMR and Quantitative Elemental Analysis Report.
Solubility: Soluble in DMSO, alcohols and acetone.APIM050359: APREMILAST
CAS No.: 608141-41-9.
Purity: >99.5% chemical and optical purity by HPLC and chiral HPLC.
QC: HPLC, 1H-NMR, chiral HPLC, and quantitative elemental analysis report.
Solubility: Refer to Certificate.BP001950-CA70: Recombinant Human Ephrin A1 (EFNA1) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001950-PRO-971: Recombinant Human Ephrin A1 (EFNA1) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.C075P: Etanercept Biosimilar
Recombinant protein composed of the soluble TNF receptor 2 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
Specificity/Sensitivity: The etanercept biosimilar protein specifically binds to the human TNF alpha.
Applications: Functional assays, and those assays for studying biological pathways affected by etanercept.C003: Humira Biosimilar Stable Cell Line (CHO)
The yield of Humira biosimilar from the CHO stable cell line was above 2.0 g/L in a 50 liter manufacturing.
C011P: Infliximab Biosimilar, TNF alpha Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody Infliximab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Infliximab.BP000651-ENZ-086: Recombinant Human Lipoprotein Lipase
Source: E. coli-derived.